Literature DB >> 3330423

Enzymes involved in triglyceride hydrolysis.

M R Taskinen, T Kuusi.   

Abstract

The lipolytic enzymes LPL and HL play important roles in the metabolism of lipoproteins and participate in lipoprotein interconversions. LPL was originally recognized to be the key enzyme in the hydrolysis of chylomicrons and triglyceride, but it also turned out to be one determinant of HDL concentration in plasma. When LPL activity is high, chylomicrons and VLDL are rapidly removed from circulation and a concomitant rise of the HDL2 occurs. In contrast, low LPL activity impedes the removal of triglyceride-rich particles, resulting in the elevation of serum triglycerides and a decrease of HDL (HDL2). Concordant changes of this kind in LPL and HDL2 are induced by many physiological and pathological perturbations. Finally, the operation of LPL is also essential for the conversion of VLDL to LDL. This apparently clear-cut role of LPL in lipoprotein interconversions is contrasted with the enigmatic actions of HL. The enzyme was originally thought to participate in the catalyses of chylomicron and VLDL remnants generated in the LPL reaction. However, substantial in vitro and in vivo data indicate that HL is a key enzyme in the degradation of plasma HDL (HDL2) in a manner which opposes LPL. A scheme is presented for the complementary actions of the two enzymes in plasma HDL metabolism. In addition, recent studies have attributed a role to HL in the catabolism of triglyceride-rich lipoproteins, particularly those containing apo E. However, this function becomes clinically important only under conditions where the capacity of the LPL-mediated removal system is exceeded. Such a situation may arise when the input of triglyceride-rich particles (chylomicrons and/or VLDL) is excessive or LPL activity is decreased or absent.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3330423     DOI: 10.1016/s0950-351x(87)80027-7

Source DB:  PubMed          Journal:  Baillieres Clin Endocrinol Metab        ISSN: 0950-351X


  6 in total

1.  Fibrates and triglyceride metabolism.

Authors:  P Schwandt
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

2.  Changes of lipolytic enzymes cluster with insulin resistance syndrome. Botnia Study Group.

Authors:  P Knudsen; J Eriksson; S Lahdenperä; J Kahri; L Groop; M R Taskinen
Journal:  Diabetologia       Date:  1995-03       Impact factor: 10.122

3.  Lipoprotein lipase and hepatic lipase: their relationship with HDL subspecies Lp(A-I) and Lp(A-I,A-II).

Authors:  Marian C Cheung; Shalamar D Sibley; Jerry P Palmer; John F Oram; John D Brunzell
Journal:  J Lipid Res       Date:  2003-06-01       Impact factor: 5.922

4.  Metabolism of triglyceride-rich lipoproteins during alimentary lipemia.

Authors:  F Karpe; G Steiner; T Olivecrona; L A Carlson; A Hamsten
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

5.  No evidence for linkage between familial hypertriglyceridemia and apolipoprotein B, apolipoprotein C-III or lipoprotein lipase genes.

Authors:  T Heliö; A Palotie; T Sane; M J Tikkanen; K Kontula
Journal:  Hum Genet       Date:  1994-09       Impact factor: 4.132

6.  Benzyl isothiocyanate disturbs lipid metabolism in rats in a way independent of its thyroid impact following in vivo long-term treatment and in vitro adipocytes studies.

Authors:  Monika Okulicz; Iwona Hertig
Journal:  J Physiol Biochem       Date:  2012-07-15       Impact factor: 4.158

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.